Heath Winners & Losers: Biogen Idec, Elan - Street.Com

Heath Winners & Losers: Biogen Idec, Elan - Street.Com
After a nice rise early in the day, health stocks settled back into neutral territory on Tuesday. The Nasdaq biotechnology index landed up 0.2% while the Amex index gave up 0.2%. A few regulatory items peppered otherwise light news. Amylin AMLN and

Study Could Aid Bird Flu Drugs - Post Chronicle
University of Texas and Rutgers researchers have reported a discovery that could help scientists develop drugs to fight bird flu and other influenza strains. The scientists identified the three-dimensional structure of an influenza A virus protein

New flu vaccine approach hopeful, Novavax says - Reuters
WASHINGTON (Reuters) - A new type of bird flu vaccine that uses a mock version of the virus appears to protect people against infection and is safe enough to continue testing, Novavax Inc. said on Tuesday. The Rockville, Maryland-based biotech

Post a Comment

Your email is never published nor shared. Required fields are marked *